All In Biotech

Drug Trial Radar · NCT06555783

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2

A Phase 2, Parallel-Group, Dose-Range-Finding Study With Randomized Double-Blind Treatment and Open-Label Periods to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Narcolepsy Type 2

Last checked: Nov 19, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

93

Actual

Start

Jul 26, 2024

Primary completion

Nov 11, 2025

Study completion Nov 21, 2025

Sponsor

Lead sponsor
Alkermes, Inc.Industry
Sponsor type
Industry
First posted
Aug 15, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to measure the safety and decrease in sleepiness in subjects with narcolepsy type 2 (NT2) when taking ALKS 2680 tablets compared to placebo tablets.

Conditions

  • Narcolepsy Type 2

Interventions

  • ALKS 2680Drug

    Oral tablet containing ALKS 2680

  • PlaceboDrug

    Oral tablet containing placebo for once daily administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Mean Sleep Latency (MSL) on the Maintenance Wakefulness Test (MWT)Time frame: Baseline to Week 8
  2. Change in Epworth Sleepiness Scale (ESS)Time frame: Baseline to week 8

Locations

47 sites in 8 countries. Site status is shown where the registry gives one.

  • Alkermes Investigator Site

    Little Rock, Arkansas

  • Alkermes Investigator Site

    Los Angeles, California

  • Alkermes Investigator Site

    Redwood City, California

  • Alkermes Investigator Site

    San Francisco, California

  • Alkermes Investigator Site

    Santa Ana, California

  • Alkermes Investigational Site

    Aurora, Colorado

  • Alkermes Investigator Site

    Colorado Springs, Colorado

  • Alkermes Investigator Site

    Brandon, Florida

  • Alkermes Investigator Site

    Miami, Florida

  • Alkermes Investigator Site

    Winter Park, Florida

  • Alkermes Investigator Site

    Atlanta, Georgia

  • Alkermes Investigational Site

    Macon, Georgia

  • Alkermes Investigator Site

    Stockbridge, Georgia

  • Alkermes Investigational Site

    Peoria, Illinois

  • Alkermes Investigator Site

    Lansing, Michigan

  • Alkermes Investigator Site

    Sterling Heights, Michigan

  • Alkermes Investigator Site

    Lincoln, Nebraska

  • Alkermes Investigator Site

    Middletown, New Jersey

  • Alkermes Investigator Site

    Denver, North Carolina

  • Alkermes Investigator Site

    Huntersville, North Carolina

  • Alkermes Investigator Site

    Canton, Ohio

  • Alkermes Investigator Site

    Cincinnati, Ohio

  • Alkermes Investigator Site

    Cincinnati, Ohio

  • Alkermes Investigational Site

    Cleveland, Ohio

  • Alkermes Investigator Site

    Abington, Pennsylvania

  • Alkermes Investigational Site

    Philadelphia, Pennsylvania

  • Alkermes Investigator Site

    Wyomissing, Pennsylvania

  • Alkermes Investigator Site

    Columbia, South Carolina

  • Alkermes Investigator Site

    Cordova, Tennessee

  • Alkermes Investigator Site

    Austin, Texas

  • Alkermes Investigator Site

    San Antonio, Texas

  • Alkermes Investigational Site

    Sugar Land, Texas

  • Alkermes Investigational Site

    Madison, Wisconsin

  • Alkermes Investigator Site

    Macquarie Park, New South Wales, Australia

  • Alkermes Investigator Site

    Bedford Park, South Australia, Australia

  • Alkermes Investigational Site

    Alken, Belgium

  • Alkermes Investigational Site

    Namur, Belgium

  • Alkermes Investigational Site

    Prague, Czechia

  • Alkermes Investigational Site

    Bordeaux, France

  • Alkermes Investigational Site

    La Tronche, France

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.